Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior

AIDS

Volumn 18, Issue 5, 2004, Pages 787-792

  Martin, Jeffrey N ^a,b,c   Roland, Michelle E ^c   Neilands, Torsten B ^b   Krone, Melissa R ^b   Bamberger, Joshua D ^d   Kohn, Robert P ^d   Chesney, Margaret A ^b   Franses, Karena ^b   Kahn, James O ^c   Coates, Thomas J ^b   Katz, Mitchell H ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

Anti HIV agents; Behavioral disinhibition; HIV infections drug therapy prevention and control; Postexposure prophylaxis; Risk taking; Sex behavior

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE; EVALUATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

ADULT; ANTI-HIV AGENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES;

EID: 11144355594     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200403260-00010     Document Type: Article

References (28)

1. US Public Health Service. Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep 2001, 50:1-52.
2. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997, 337:1485-1490.
3. Otten RA, Smith DK, Adams DR, Pullium JK, Jackson E, Kim CN, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000, 74: 9771-9775.
4. Royce RA, Sena A, Cates W, Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997, 336:1072-1078.
5. Mayer KH, Kwong J, Church D, LaSalvia T, Lo W, MacGovern T, et al. HIV prophylaxis after non-occupational exposure in Massachusetts. National HIV Prevention Conference. Atlanta, 1999.
6. Kwong J, Mayer KH, LaSalvia T, Church D, Peterson N, Pares-Avila J, et al. Non-occupational HIV post exposure prophylaxis at a Boston community health center. National HIV Prevention Conference. Atlanta, 1999 [abstract 362].
7. Torres R. The first nonoccupational post-exposure prophylaxis (PEP) pilot program in NYC. XIII International Conference on AIDS. Durban, July, 2000 [abstract WePeC4307].
8. Kahn JO, Martin JN, Roland ME, Bamberger JD, Chesney MA, Chambers D, et al. Feasibility of post exposure prophylaxis (PEP) against human immunodeficiency virus infection following sexual or injection drug use exposures: the San Francisco PEP Study. J Infect Dis 2001, 183:707-714.
9. Kunches LM, Meehan TM, Boutwell RC, McGuire JF. Survey of nonoccupational HIV postexposure prophylaxis in hospital emergency departments. J Acquir Immune Defic Syndr 2001, 26:263-265.
10. Beardsell A, Lai C, Hogg R, McLeod W, Yip B. Utilization and adherence in a population-based post-exposure prophylaxis program. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, January-February, 1999 [abstract 214].
11. Bernasconi E, Jost J, Ledergerber B, Hirschel B, Francioli P, Sudre P. Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000. Swiss Med Wkly 2001, 131:433-437.
12. Correll P, Smith D, Hendry O, Grulich A. Non occupational HIV post exposure prophylaxis (PEP) in Australia. XIII International Conference on AIDS. Durban, July, 2000 [abstract WePeC4420].
13. Debab Y, Fartoukh C, Abboud P, Gueit I, Borsa-Lebas F, Caron F. HIV post-exposure prophylaxis: Influence of the mode of exposure on the compliance and tolerance of the procedure. XIII International Conference on AIDS. Durban, July, 2000 [abstract WePpC1448].
14. Derouineau J, Dhotte P, Buttet P. A retrospective study of 83 post exposure prophylaxis (PEP) tolerability in health dispensary figuier. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, September, 2000 [abstract 348].
15. Friedman R, Rodrigues J, Fernandes M, Moreira I, Schechter M, Harrison L. Acceptability of post-sexual-exposure chemoprophylaxis for the prevention of HIV infection in Brazil. XII International Conference on AIDS. Durban, July, 2000 [abstract TuOrC315].
16. Harrison L, Do Lago R, Moreira R, Schechter M. Demand for post-sexual-exposure chemoprophylaxis for the prevention of HIV infection in Brazil. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September, 1999 [abstract 575].
17. Laporte A, Jourdan N, Bouvet E, Lamontagne F, Pillonel J, Desenclos JC. Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians' experiences and attitudes. AIDS 2002, 16:397-405.
18. Rabaud C, Bevilacqua S, Beguinot I, Dorvaux V, Schuhmacher H, May T, et al. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection. Clin Infect Dis 2001, 32:1494-1495.
19. Rey D, Bendiane MK, Moatti JP, Wellings K, Danziger R, MacDowall W. Post-exposure prophylaxis after occupational and non-occupational exposures to HIV: an overview of the policies implemented in 27 European countries. AIDS Care 2000, 12:695-701.
20. Robillard P, Roy E, Brassard J. Management of patients consulting for non-occupational exposure to HIV (NOEXP) in a sample of Quebec physicians. National HIV Prevention Conference. Atlanta, 1999 [abstract 177].
21. Wiebe ER, Comay SE, McGregor M, Ducceschi S. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service. Can Med Assoc J 2000, 162:641-645.
22. Bandura A. Social cognitive theory and exercise of control over HIV infection. In: Preventing AIDS: Theories and Methods of Behavioral Interventions. Edited by DiClemente RJ, Peterson JL. New York: Plenum; 1994:25-59.
23. Chesney M, Folkman S, Chambers D. Coping effectiveness training for men living with HIV: preliminary findings. Int J STD AIDS 1996, 7(Suppl 2):75-82.
24. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford Press; 1991.
25. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
26. Mirowsky J, Ross CE. Age and depression. J Health Soc Behav 1992, 33:187-205.
27. Cohen, S., Kamarck, T., Mermelstein, R. A global measure of perceived stress. J Health Soc Behav 1983, 24:385-396.
28. McFarland W. San Francisco Department of Public Health HIV Consensus Meeting. San Francisco, January, 2001. San Francisco, CA: Department of Public Health.